Blue Jet Healthcare Limited (NSE:BLUEJET)

Market Cap	65.24B -50.1%
Revenue (ttm)	10.53B +20.6%
Net Income	2.94B +25.1%
EPS	16.92 +25.0%
Shares Out	173.47M
PE Ratio	22.23
Forward PE	24.11
Dividend	1.20 (0.32%)
Ex-Dividend Date	Sep 19, 2025

Volume	357,342
Average Volume	1,248,009
Open	376.90
Previous Close	375.60
Day's Range	373.85 - 382.65
52-Week Range	352.55 - 1,027.80
Beta	-0.35
RSI	40.11
Earnings Date	May 25, 2026

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1968
• Employees: 196
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BLUEJET

Financial Performance

In fiscal year 2025, Blue Jet Healthcare's revenue was 10.30 billion, an increase of 44.74% compared to the previous year's 7.12 billion. Earnings were 3.05 billion, an increase of 86.38%.